En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
13754.1;6 PFFLE-LS
Titre du projet
Finalization of the development of the pumping mechanism of an implantable medical device dedicated to preclinical research
Titre du projet anglais
Finalization of the development of the pumping mechanism of an implantable medical device dedicated to preclinical research

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
-
Anzeigen
-
Anzeigen
Résumé des résultats (Abstract)
-
Anzeigen
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Anglais)
Finalization of the development of the pumping mechanism of an implantable medical device dedicated to preclinical research
Description succincte
(Français)
Finalization of the development of the pumping mechanism of an implantable medical device dedicated to preclinical research
Résumé des résultats (Abstract)
(Anglais)
Antlia SA is a healthcare start-up that serves the animal preclinical and veterinary markets Project delivery is to finalize the development of the volumetric pumping system of the pump to launch the product on the basis of the development made on ithetis¿ ithetis¿ is the world¿s smallest and most advanced implantable drug delivery device (micro IDDD) LHTC @ EPFL is specialized in the development of active or telemetrically-controlled medical devices Clients contracts signed, projected turnover in 2013 will be 1.5 mCHF, 2014 2.4 mCHF
Résumé des résultats (Abstract)
(Français)
Antlia SA is a healthcare start-up that serves the animal preclinical and veterinary markets Project delivery is to finalize the development of the volumetric pumping system of the pump to launch the product on the basis of the development made on ithetis¿ ithetis¿ is the world¿s smallest and most advanced implantable drug delivery device (micro IDDD) LHTC @ EPFL is specialized in the development of active or telemetrically-controlled medical devices Clients contracts signed, projected turnover in 2013 will be 1.5 mCHF, 2014 2.4 mCHF